The novel echo‐guided ProGlide technique during percutaneous transfemoral transcatheter aortic valve implantation

Objectives

The aim of this study was to assess clinical benefit of the Echo‐guided ProGlide technique in patients undergoing percutaneous transfemoral transcatheter aortic valve implantation (TF‐TAVI).

Background

The efficacy of the Echo‐guided ProGlide technique during percutaneous TF‐TAVI was not previously clarified.

Methods

A total of 121 consecutive patients who underwent percutaneous TF‐TAVI at our institution between February 2014 and July 2017 were enrolled in this study. According to the introduction of this novel technique in March 2016, patients were divided into two groups (echo‐guided group who underwent TAVI from March 2016 to July 2017, n = 63; not echo‐guided group who underwent TAVI from February 2014 to February 2016, n = 58). The incidence of major vascular complications, defined per the Valve Academic Research Consortium‐2 criteria, and ProGlide complications including acute femoral artery stenosis or occlusion and bleeding requiring any intervention.

Results

The incidence of major vascular complication and ProGlide complication were significantly lower in the echo‐guided group than in not echo‐guided group (1.6% vs 17.2%, P < 0.002; 1.6% vs 15.5%, P = 0.003; respectively). Use of the Echo‐guided ProGlide technique was independently associated with prevention of ProGlide complications (odds ratio, 0.11; 95% confidential interval, 0.01‐0.76; P = 0.03).

Conclusions

This novel Echo‐guided ProGlide technique was associated with a lower rate of major vascular complications, particularly ProGlide complications during percutaneous TF‐TAVI.